Provillus Hair Loss Treatment for Men and Women

Peptide stimulation for DHT baldness shows promise

Early clinical trials of a natural benzyl amino peptide stimulation treatment in conjunction with a DHT organic equol reduction treatment for hair loss is showing promise in re-growing hair in alopecia patients, a condition that affects 50 million men and 30 million women in America.

Peptides naturally activate, when working correctly as in the lucky 20% who do not suffer hair loss problems, an obscure receptor that sits on the surface of hair follicle cells. These peptides activate hair follicles into the growth phase.

These trials demonstrate that it is possible to get human hair follicles to recognize peptide stimulation and for them to then activate the growth stage. Peptides are named due to there flexible binding characteristics on the hair follicle cells.

Hair Loss Inherited From The Mother There are two separate natural sequences of peptides both of which can switch the hair follicle into the growth phase.

“It now appears that it is possible to restore follicles on the scalp to a healthy condition with the conjunction of oral molecular DHT inhibitor treatment containing equol with topical peptide stimulation treatments. The implications are profound” said Dr.Yang, M.D., Ph.D., Director of Clinical Pharmacology, Hospital of Prevention & Therapeutics, Shashi, Hubei, China.

Dr. Yang went on to say “Early indications are that even in totally bald areas of the scalp many hair follicles are still alive but just miniaturized and can be switched back on again with the right peptide messengers.”

Hair loss patients received the new organic formula in trials lasting six months in both oral and topical benzyl amino mixtures to enhance stronger hair follicle growth cycle uptake.

Over 90% of these patients, from first signs of thinning to advanced pattern baldness, showed noticeable hair growth density improvements.